Sinphar Pharmaceutical Co (TPE:1734) FFO


TPE:1734 Sinphar Pharmaceutical Co Ltd TPE:1734
80 GF Score
Price NT$33.30
GF Value NT$33.16
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Sinphar Pharmaceutical Co FFO?

FFO (Funds from operations) only applies to REITs.

TPE:1734
80GF Score
Sinphar Pharmaceutical Co Ltd TPE:1734
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Sinphar Pharmaceutical Co (TPE:1734) Overvalued in 2026?

Based on GuruFocus' analysis, Sinphar Pharmaceutical Co stock appears to be overvalued. The current stock price of NT$33.30 is trading 0.4% above its estimated GF Value™ of NT$33.16. GuruFocus considers Sinphar Pharmaceutical Co to be Fairly Valued.

Key valuation signals for TPE:1734:

  • FFO:
  • GF Value™: NT$33.16 vs. price of NT$33.30 (0.4% above fair value)
  • GF Score™: 80/100 with 2 warning signs

No single metric tells the full story. See the TPE:1734 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sinphar Pharmaceutical Co Business Description

Address No.84, Zhongshan Road, Dongshan Township, Zhongshan Village, Yilan, TWN, 269
Sinphar Pharmaceutical Co Ltd operates in the pharmaceutical segment. The company mainly engages in the production, processing, and trading of various Chinese medicines, medicinal cosmetics, and nutrients. The company's reportable segments are; Pharmaceuticals which derives key revenue, Healthy food, and others. Geographically, the company generates a majority of its revenue from Taiwan and the rest from China, Vietnam, Indonesia, America, and other regions.
80GF Score

Get the complete analysis for TPE:1734

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$33.30
Price
NT$33.16
GF Value